Dr. Gerard A. Ballanco Jr., M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 539 E Prudhomme St, Opelousas, LA 70570 Phone: 337-942-6883 Fax: 337-942-6830 |
Dr. Paula M. Sharkey, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 539 E Prudhomme St, Opelousas, LA 70570 Phone: 337-942-6883 Fax: 337-942-6883 |
Mr. Calvin Dale Vidrine, CRA RJ RN Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 174 Grant Rd, Opelousas, LA 70570 Phone: 337-594-9637 Fax: 337-948-4556 |
Carol Pratt Becker, MD Radiology - Diagnostic Radiology Medicare: Medicare Enrolled Practice Location: 539 E Prudhomme St, Opelousas, LA 70570 Phone: 337-942-6883 Fax: 337-942-6883 |
Dr. Richard G. Lastrapes, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 539 E Prudhomme St, Opelousas, LA 70570 Phone: 337-942-6883 Fax: 337-942-6883 |
Dr. Edward Daniel Willett, Radiology - Diagnostic Radiology Medicare: Medicare Enrolled Practice Location: 539 East Prudhomme St, Opelousas, LA 70570 Phone: 337-942-6883 Fax: 337-942-6883 |
News Archive
An Emory University neuro-imaging study shows that personal values that people refuse to disavow, even when offered cash to do so, are processed differently in the brain than those values that are willingly sold.
The federal government has awarded investigators at The Johns Hopkins University's schools of medicine and public health a multimillion-dollar, five-year grant to continue research designed to identify the causes of frailty in older adults, and speed the development of interventions to slow or stop it.
Freescale Semiconductor today announced it has received ZigBee Certified product status for its ZigBee Health Care wireless health and wellness processing platforms. The ZigBee Certified products status is awarded to products that have been tested and met criteria for interoperability that enable wireless devices to securely and reliably monitor and manage noncritical, low-acuity health care services.
deCODE genetics, Inc. today announced that it has completed the previously-announced sale of its Iceland-based subsidiary deCODE genetics ehf (also known as Islensk erfdagreining) and its drug discovery and development programs to Saga Investments LLC, a private company. The sale followed approval by the U.S. Bankruptcy Court for the District of Delaware in deCODE genetics Inc.'s ongoing proceeding under Chapter 11 of the U.S. Bankruptcy Code.
› Verified 4 days ago